Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Cost-effectiveness of bioimpedance-guided fluid management in patients undergoing haemodialysis : the BISTRO RCT

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • معلومة اضافية
    • بيانات النشر:
      NIHR Health Technology Assessment programme
    • الموضوع:
      2024
    • Collection:
      The University of Warwick: WRAP - Warwick Research Archive Portal
    • نبذة مختصرة :
      Background The BioImpedance Spectroscopy to maintain Renal Output randomised controlled trial investigated the effect of bioimpedance spectroscopy added to a standardised fluid management protocol on the risk of anuria and preservation of residual kidney function (primary trial outcomes) in incident haemodialysis patients. Despite the economic burden of kidney disease, the cost-effectiveness of using bioimpedance measurements to guide fluid management in haemodialysis is not known. Objectives To assess the cost-effectiveness of bioimpedance-guided fluid management against current fluid management without bioimpedance. Design Within-trial economic evaluation (cost–utility analysis) carried out alongside the open-label, multicentre BioImpedance Spectroscopy to maintain Renal Output randomised controlled trial. Setting Thirty-four United Kingdom outpatient haemodialysis centres, both main and satellite units, and their associated inpatient hospitals. Participants Four hundred and thirty-nine adult haemodialysis patients with > 500 ml urine/day or residual glomerular filtration rate > 3 ml/minute/1.73 m 2 . Intervention The study intervention was the incorporation of bioimpedance technology-derived information about body composition into the clinical assessment of fluid status in patients with residual kidney function undergoing haemodialysis. Bioimpedance measurements were used in conjunction with usual clinical judgement to set a target weight that would avoid excessive fluid depletion at the end of a dialysis session. Main outcome measures The primary outcome measure of the BioImpedance Spectroscopy to maintain Renal Output economic evaluation was incremental cost per additional quality-adjusted life-year gained over 24 months following randomisation. In the main (base-case) analysis, this was calculated from the perspective of the National Health Service and Personal Social Services. Sensitivity analyses explored the impact of different scenarios, sources of resource use data and value sets. Results The ...
    • File Description:
      application/pdf
    • Relation:
      https://wrap.warwick.ac.uk/id/eprint/187885/1/3046158.pdf; Zanganeh, Mandana, Belcher, John, Fotheringham, James, Coyle, David, Lindley, Elizabeth J., Keane, David F., Caskey, Fergus J., Dasgupta, Indranil, Davenport, Andrew, Farrington, Ken, Mitra, Sandip, Ormandy, Paula, Wilkie, Martin, Macdonald, Jamie H., Solis-Trapala, Ivonne, Sim, Julius, Davies, Simon J. and Andronis, Lazaros (2024) Cost-effectiveness of bioimpedance-guided fluid management in patients undergoing haemodialysis : the BISTRO RCT. Health Technology Assessment . doi:10.3310/JYPR4287 ISSN 1366-5278. (In Press)
    • الرقم المعرف:
      10.3310/JYPR4287
    • الدخول الالكتروني :
      https://wrap.warwick.ac.uk/id/eprint/187885/
      https://wrap.warwick.ac.uk/id/eprint/187885/1/3046158.pdf
      https://doi.org/10.3310/JYPR4287
    • Rights:
      cc_by_4
    • الرقم المعرف:
      edsbas.E7F31563